SAN ANTONIO -- Men with intermediate- and high-risk prostate cancer treated with external-beam pelvic radiotherapy (EBRT) had better quality of life (QOL) outcomes when the combined prostate ...

Prostate cancer patients with 4-year prostate-specific antigen (PSA) levels at 0.2 ng/mLl or less after low dose rate (LDR) prostate brachytherapy can be considered cured, according to a study led by ...

ALEXANDRIA, Va., Toronto, Canada - The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario today issued a joint clinical practice guideline update on brachytherapy (internal radiation ...

Adding supplemental external beam radiotherapy (EBRT) did not improve outcomes in higher-risk cancer patients who had brachytherapy, according to the long-term results of two trials. Specifically, ...

Brachytherapy-based regimens appear to be effective salvage treatment for localized radiorecurrent prostate cancer, investigators reported at the 2024 ASCO Genitourinary Cancers Symposium in San ...

Pelvic second malignancy occurred twice as often after brachytherapy for prostate cancer as compared with radical prostatectomy, a large retrospective review showed. Second pelvic malignancy -- ...

Approximately one in eight men will develop prostate cancer, which is the second-leading cause of cancer death in American men and typically affects patients who are 65 or older. Fortunately, the ...

The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer Men with prostate cancer stage cT1c-T2bN0M0, ...